CENTOGENE, the worldwide leader in diagnosing, profiling, tracking and elucidating rare diseases for patients, clinicians and pharmaceutical partners, today announced that it will make a formal presentation at the 36th Annual J.P. Morgan Healthcare Conference. The company will provide a corporate update on Thursday, January 11, 2018 at 11:00 am PT.